Enovis Corporation Current Ratio 2010-2024 | ENOV
Enovis Corporation current ratio from 2010 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Enovis Corporation Current Ratio Historical Data |
| Date |
Current Assets |
Current Liabilities |
Current Ratio |
| 2024-09-30 |
$1.20B |
$0.53B |
2.27 |
| 2024-06-30 |
$1.17B |
$0.52B |
2.26 |
| 2024-03-31 |
$1.15B |
$0.55B |
2.10 |
| 2023-12-31 |
$0.90B |
$0.37B |
2.43 |
| 2023-09-30 |
$0.85B |
$0.36B |
2.40 |
| 2023-06-30 |
$0.89B |
$0.35B |
2.51 |
| 2023-03-31 |
$0.83B |
$0.35B |
2.38 |
| 2022-12-31 |
$0.80B |
$0.57B |
1.41 |
| 2022-09-30 |
$1.01B |
$0.85B |
1.18 |
| 2022-06-30 |
$1.08B |
$0.81B |
1.33 |
| 2022-03-31 |
$2.35B |
$1.45B |
1.62 |
| 2021-12-31 |
$2.30B |
$1.02B |
2.25 |
| 2021-09-30 |
$1.73B |
$0.98B |
1.77 |
| 2021-06-30 |
$1.48B |
$0.90B |
1.64 |
| 2021-03-31 |
$2.08B |
$1.56B |
1.33 |
| 2020-12-31 |
$1.36B |
$0.81B |
1.68 |
| 2020-09-30 |
$1.29B |
$0.79B |
1.64 |
| 2020-06-30 |
$1.23B |
$0.76B |
1.62 |
| 2020-03-31 |
$1.58B |
$0.82B |
1.93 |
| 2019-12-31 |
$1.40B |
$0.86B |
1.64 |
| 2019-09-30 |
$3.50B |
$1.51B |
2.32 |
| 2019-06-30 |
$3.64B |
$1.60B |
2.28 |
| 2019-03-31 |
$2.41B |
$1.57B |
1.53 |
| 2018-12-31 |
$1.96B |
$1.20B |
1.63 |
| 2018-09-30 |
$1.95B |
$1.07B |
1.83 |
| 2018-06-30 |
$1.95B |
$1.08B |
1.81 |
| 2018-03-31 |
$2.16B |
$1.10B |
1.98 |
| 2017-12-31 |
$2.07B |
$1.10B |
1.89 |
| 2017-09-30 |
$2.32B |
$1.29B |
1.80 |
| 2017-06-30 |
$1.96B |
$1.15B |
1.71 |
| 2017-03-31 |
$1.78B |
$1.08B |
1.65 |
| 2016-12-31 |
$1.74B |
$1.06B |
1.64 |
| 2016-09-30 |
$1.80B |
$1.08B |
1.68 |
| 2016-06-30 |
$1.79B |
$1.09B |
1.64 |
| 2016-03-31 |
$1.79B |
$1.10B |
1.63 |
| 2015-12-31 |
$1.73B |
$1.12B |
1.55 |
| 2015-09-30 |
$2.00B |
$1.21B |
1.66 |
| 2015-06-30 |
$2.01B |
$1.20B |
1.67 |
| 2015-03-31 |
$2.02B |
$1.26B |
1.61 |
| 2014-12-31 |
$2.07B |
$1.28B |
1.62 |
| 2014-09-30 |
$2.22B |
$1.37B |
1.62 |
| 2014-06-30 |
$2.41B |
$1.42B |
1.70 |
| 2014-03-31 |
$2.34B |
$1.31B |
1.78 |
| 2013-12-31 |
$2.13B |
$1.38B |
1.54 |
| 2013-09-30 |
$2.37B |
$1.32B |
1.79 |
| 2013-06-30 |
$2.29B |
$1.25B |
1.83 |
| 2013-03-31 |
$1.99B |
$1.27B |
1.57 |
| 2012-12-31 |
$2.13B |
$1.18B |
1.80 |
| 2012-09-30 |
$2.23B |
$1.22B |
1.83 |
| 2012-06-30 |
$2.30B |
$1.24B |
1.86 |
| 2012-03-31 |
$2.34B |
$1.20B |
1.95 |
| 2011-12-31 |
$0.35B |
$0.24B |
1.46 |
| 2011-09-30 |
$0.35B |
$0.21B |
1.63 |
| 2011-06-30 |
$0.34B |
$0.21B |
1.67 |
| 2011-03-31 |
$0.33B |
$0.21B |
1.61 |
| 2010-12-31 |
$0.32B |
$0.19B |
1.68 |
| 2010-09-30 |
$0.29B |
$0.17B |
1.72 |
| 2010-06-30 |
$0.28B |
$0.14B |
1.95 |
| 2010-03-31 |
$0.29B |
$0.15B |
1.94 |
| 2009-12-31 |
$0.30B |
$0.15B |
1.97 |
| 2009-09-30 |
$0.31B |
$0.16B |
1.99 |
| 2009-06-30 |
$0.29B |
$0.14B |
2.07 |
| 2009-03-31 |
$0.28B |
$0.14B |
2.02 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MEDICAL INFO SYS |
$2.428B |
$1.707B |
|
Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
| Veeva Systems Inc. (VEEV) |
US |
$36.657B |
54.02 |
| Hims & Hers Health, Inc. (HIMS) |
US |
$10.767B |
273.78 |
| Tempus AI, Inc. (TEM) |
US |
$10.720B |
0.00 |
| Inspire Medical Systems, Inc. (INSP) |
US |
$5.261B |
102.50 |
| iRhythm Technologies (IRTC) |
US |
$3.752B |
0.00 |
| Privia Health Group, Inc. (PRVA) |
US |
$2.942B |
245.20 |
| Clover Health Investments, Corp. (CLOV) |
US |
$2.205B |
0.00 |
| Azenta, Inc. (AZTA) |
US |
$2.045B |
95.21 |
| Omnicell, Inc. (OMCL) |
US |
$1.840B |
40.12 |
| Schrodinger, Inc. (SDGR) |
US |
$1.650B |
0.00 |
| Phreesia, Inc. (PHR) |
US |
$1.640B |
0.00 |
| 10x Genomics (TXG) |
US |
$1.333B |
0.00 |
| Butterfly Network, Inc. (BFLY) |
US |
$0.916B |
0.00 |
| Talkspace, Inc. (TALK) |
US |
$0.508B |
300.50 |
| Fulgent Genetics, Inc. (FLGT) |
US |
$0.503B |
0.00 |
| Standard BioTools Inc. (LAB) |
US |
$0.484B |
0.00 |
| TruBridge, Inc. (TBRG) |
US |
$0.422B |
122.87 |
| Pulmonx Corporation (LUNG) |
US |
$0.354B |
0.00 |
| Nyxoah SA (NYXH) |
BE |
$0.352B |
0.00 |
| Health Catalyst, Inc. (HCAT) |
US |
$0.318B |
0.00 |
| SOPHiA GENETICS SA (SOPH) |
CH |
$0.266B |
0.00 |
| American Well Corporation (AMWL) |
US |
$0.183B |
0.00 |
| EUDA Health Holdings Limited (EUDA) |
SG |
$0.098B |
0.00 |
| MDxHealth SA (MDXH) |
BE |
$0.088B |
0.00 |
| P3 Health Partners Inc. (PIII) |
US |
$0.075B |
0.00 |
| 111, Inc. Sponsored ADR (YI) |
CN |
$0.072B |
0.00 |
| CareCloud, Inc. (CCLD) |
US |
$0.058B |
0.00 |
| HeartBeam, Inc. (BEAT) |
US |
$0.055B |
0.00 |
| Outset Medical, Inc. (OM) |
US |
$0.047B |
0.00 |
| Zepp Health Corporation Sponsored ADR (ZEPP) |
CN |
$0.045B |
0.00 |
| SHL Telemedicine Ltd. Unsponsored ADR (SHLT) |
IL |
$0.038B |
0.00 |
| Zhongchao Inc. (ZCMD) |
CN |
$0.035B |
0.00 |
| Movano Inc. (MOVE) |
US |
$0.033B |
0.00 |
| Bullfrog AI Holdings Inc. (BFRG) |
US |
$0.025B |
0.00 |
| MSP Recovery, Inc. (MSPR) |
US |
$0.016B |
0.00 |
| Streamline Health Solutions, Inc. (STRM) |
US |
$0.015B |
0.00 |
| Precipio, Inc. (PRPO) |
US |
$0.015B |
0.00 |
| ImmunoPrecise Antibodies Ltd. (IPA) |
CA |
$0.012B |
0.00 |
| Mobile-health Network Solutions (MNDR) |
SG |
$0.012B |
0.00 |
| Strata Skin Sciences, Inc. (SSKN) |
US |
$0.011B |
0.00 |
| Predictive Oncology Inc. (POAI) |
US |
$0.010B |
0.00 |
| Syra Health Corp. (SYRA) |
US |
$0.005B |
0.00 |
| Tivic Health Systems, Inc. (TIVC) |
US |
$0.004B |
0.00 |
| HeartSciences Inc. (HSCS) |
US |
$0.004B |
0.00 |
| Healthcare Triangle, Inc. (HCTI) |
US |
$0.003B |
0.00 |
| Future Health ESG Corp. (FHLT) |
US |
$0.000B |
0.00 |
